SCHEMBL6710593

SCHEMBL6710593

CC(C)c1ccc(CC(=O)Nc2cccc3cc(C(=O)Nc4ccc(Cl)cc4-c4nnn[nH]4)[nH]c23)cc1

nearest known ligand 0.38

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP14 Q460N5 1/20 0.38
NLRP3 Q96P20 1/20 0.36
PYGL P06737 4/20 0.36
MAP3K5 Q99683 1/20 0.36
MAPT P10636 2/20 0.35
TP53 P04637 1/20 0.35
PLCG2 P16885 1/20 0.35
MAPK1 P28482 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
PTK2B Q14289 1/20 0.35
F10 P00742 1/20 0.35
NHERF1 O14745 1/20 0.34
LMNA P02545 1/20 0.34
POLB P06746 1/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
LPAR1 Q92633 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707755 0.94 PARP14 (0.43) PARP14PYGLTP53PLCG2PTK2B
SCHEMBL6709152 0.92 PTK2B (0.42) PARP14MAPTTP53PLCG2MAPK1
SCHEMBL6713381 0.92 NLRP3 (0.36) PARP14NLRP3MAP3K5MAPTTP53
SCHEMBL6708820 0.91 PARP14 (0.41) PARP14TP53PLCG2MAPK1NHERF1
SCHEMBL6707704 0.91 PTK2B (0.39) PARP14NLRP3PLCG2PTK2BF10
SCHEMBL6708944 0.91 PARP14 (0.39) PARP14MAPTTP53PLCG2NHERF1
SCHEMBL6714087 0.91 NPY5R (0.42) PARP14NLRP3PLCG2NHERF1LMNA
SCHEMBL6708914 0.90 MEN1 (0.47) PARP14MAPTTP53LMNAPOLB
SCHEMBL6713211 0.90 PARP14 (0.42) PARP14TP53F10NHERF1POLB
SCHEMBL6712041 0.90 LMNA (0.41) PARP14PLCG2PTK2BNHERF1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 PARP14 2597/4885NLRP3 280/4885PYGL 3737/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.